In Vitro Approaches for Assessing the Genotoxicity of Nanomaterials

Area of Science:

• Toxicology
• Nanomaterial Safety
• Genetics

Background:

• Genotoxicity, encompassing DNA damage and chromosome aberrations, is critical for chemical safety assessment.
• Nanomaterials (NMs) present unique challenges for standard genotoxicity testing, necessitating guideline adaptations.
• Existing genotoxicity testing principles for chemicals are largely applicable to NMs.

Purpose of the Study:

• To provide an overview of in vitro genotoxicity testing strategies for nanomaterials.
• To recommend a robust battery of assays for assessing NM genotoxicity.
• To highlight the utility of novel assays like the Cell Transformation Assay (CTA).

Main Methods:

• Review of in vitro genotoxicity assays relevant to nanomaterials.
• Discussion of established assays: mammalian gene mutation (Tk or HPRT), in vitro comet assay, and cytokinesis-block micronucleus assay.
• Inclusion of the Cell Transformation Assay (CTA) as a predictive tool.

Main Results:

• A combination of mammalian gene mutation, in vitro comet, and micronucleus assays is effective for NM genotoxicity assessment.
• Established genotoxicity principles are applicable, but OECD test guidelines may need NM-specific adaptations.
• The CTA shows promise for predicting NM-induced cell transformation.

Conclusions:

• A tiered in vitro testing strategy combining gene mutation, comet, and micronucleus assays is recommended for NM safety evaluation.
• Adaptations to existing OECD test guidelines are under discussion for NM genotoxicity testing.
• The CTA offers a valuable addition for assessing NM-induced cellular transformation.